Comments
FDA staff shoots down Pfizer rare disease drug
23.05.2012. | WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease....
